Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of SPP100 in essential hypertension
jRCT2080220180
- Sponsor
- Novartis
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aliskiren in essential hypertension, sponsored by Novartis.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080220180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220180.